Prestige BioPharma Limited

950210· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩6,070-3.80%

2026-08-21

Financials

Valuation Metrics

Prestige BioPharma Limited's Market Cap is ₩3648B. At end of 2025 it was ₩7722B. Ranked #554 of 2,427 in KR market (top 23%), #339 of 782 on KOSPI (top 43%), #61 of 233 in Pharmaceuticals, Biotechnology & Life Sciences (top 26%) by Market Cap.

Investment Metrics(as of 2026-08-22)

Metric	Value	Rank
Size
Market Cap	364.78B KRW	KR#554/2,427 Sec#61/233
Revenue	14.69B KRW	KR—/2,427 Sec—/233
Net Income	4.28B KRW	KR—/2,427 Sec—/233
Total Assets	790.46B KRW	KR—/2,427 Sec—/233
Net Assets	538.86B KRW	KR—/2,427 Sec—/233
Value
P/E	85.29x	KR#1,473/2,427 Sec#97/233
P/B	0.68x	KR#1,110/2,427 Sec#56/233
P/S	24.83x	KR#2,356/2,427 Sec#188/233
FCF Yield	-26.11%	KR—/2,427 Sec—/233
Profitability
ROE	0.79%	KR—/2,427 Sec—/233
ROA	0.54%	KR—/2,427 Sec—/233
Op. Margin	-470.14%	KR—/2,427 Sec—/233
Revenue Growth	1835.72%	KR—/2,427 Sec—/233
Financial Health
Debt Ratio	46.69%	KR—/2,427 Sec—/233
Total Debt	151.08B KRW	KR—/2,427 Sec—/233
FCF	-95.23B KRW	KR—/2,427 Sec—/233
Cash	122.31B KRW	KR—/2,427 Sec—/233
Current Ratio	1.27x	KR—/2,427 Sec—/233
Performance
1Y Return	-56.14%	KR#2,172/2,427 Sec#210/233
1M Return	19.02%	KR#298/2,427 Sec#34/233
From 52W High	-61.82%	KR#1,843/2,427 Sec#156/233
1Y MDD	-74.23%	KR#2,113/2,427 Sec#189/233
Trading
Volume	37,861 shares	KR#1,484/2,427 Sec#151/233
Trading Value	230.1M KRW	KR#1,351/2,427 Sec#150/233
Foreign Own.	63.32%	KR—/2,427 Sec—/233
Per Share
EPS	71 KRW	KR#1,461/2,427 Sec#103/233
BPS	8,967 KRW	KR#1,052/2,427 Sec#74/233